Dr Julia Netylko

MD
Murdoch Children’s Research Institute

Dr Julia Netylko completed her medical degree at Moscow State University, followed by residency in cardiology. She joined the Cancer Therapies group at the Murdoch Children’s Research Institute in October 2024.

Her research focuses on pharmacogenomics in paediatric oncology, with current projects investigating genetic predisposition to anthracycline-induced cardiotoxicity and genotype-informed dosing of tacrolimus in solid organ transplant recipients. Julia is passionate about advancing personalised medicine approaches to improve treatment safety and outcomes for children.

Meet more people

Dev Note:
This slider will be replaced by the cards above in the published site.
Dev Note:
This slider will be replaced by the cards above in the published site.
Dev Note:
This slider will be replaced by the cards above in the published site.
Dev Note:
This slider will be replaced by the cards above in the published site.
Dev Note:
This slider will be replaced by the cards above in the published site.

Get Involved

CoLaborate with us to accelerate childhood cancer research and innovation

Patient Stories
Collaboration
Innovation Accelerators
Survivorship and Living Well
Future Leaders
Safer Therapies
Next-Generation Therapies
Children’s Cancer CoLab and Maddie Riewoldt’s Vision Clinician-Researcher Fellowship
Future Leaders
Innovation Accelerators
Survivorship and Living Well
Safer Therapies
Next-Generation Therapies